Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-24-001038

← back to feed
Filed
Oct 28, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 28, 2024 42.1M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $333.22K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $19.24K
Total Liabilities Q3 2024 · Sep 30, 2024 $45.55K
Total Liabilities Q3 2024 · Dec 31, 2023 $100.15K
Current Assets Q3 2024 · Sep 30, 2024 $408.79K
Current Assets Q3 2024 · Dec 31, 2023 $93.39K
Total Assets Q3 2024 · Sep 30, 2024 $415.83K
Total Assets Q3 2024 · Dec 31, 2023 $93.39K
Shares Diluted Q3 2024 · Sep 30, 2023 40.36M sh
Shares Diluted Q3 2024 · Sep 30, 2023 31.43M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$251.39K
Stockholders Equity Q3 2024 · Sep 30, 2023 $8.6K
Stockholders Equity Q3 2024 · Jun 30, 2023 −$54.25K
Stockholders Equity Q3 2024 · Mar 31, 2023 −$88.99K
Stockholders Equity Q3 2024 · Dec 31, 2022 −$17.18K
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Sga Expense Q3 2024 · Sep 30, 2023 $210.29K
Sga Expense Q3 2024 · Sep 30, 2023 $441.32K
Rd Expense Q3 2024 · Sep 30, 2023 $0
Net Income Q3 2024 · Sep 30, 2023 −$57.15K
Net Income Q3 2024 · Sep 30, 2023 −$213.12K
Net Income Q3 2024 · Jun 30, 2023 −$85.26K
Net Income Q3 2024 · Mar 31, 2023 −$70.72K
Operating Income Q3 2024 · Sep 30, 2023 −$57.15K
Operating Income Q3 2024 · Sep 30, 2023 −$213.12K
Gross Profit Q3 2024 · Sep 30, 2023 $160.34K
Gross Profit Q3 2024 · Sep 30, 2023 $247.9K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $31.83K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $46.07K
Revenue Q3 2024 · Sep 30, 2023 $192.17K
Revenue Q3 2024 · Sep 30, 2023 $293.97K